Evidence map›Paper›PMID 37577263›Full record

ArticleVaccine: X2023

Using photovoice methodology to uncover individual-level, health systems, and contextual barriers to uptake of second dose of measles containing vaccine in Western Area Urban, Sierra Leone, 2020.

Shibani Kulkarni, Atsuyoshi Ishizumi, Oliver Eleeza, Palak Patel, Mohamed Feika, Samilia Kamara, Jerikatu Bangura, Unisa Jalloh, Musa Koroma, Zainab Sankoh and 6 more

Abstract read
In one paragraph

Article in Vaccine: X, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Shibani KulkarniU.S. Centers for Disease Control and Prevention, Atlanta GA, USA.
Atsuyoshi IshizumiU.S. Centers for Disease Control and Prevention, Atlanta GA, USA.
Oliver EleezaICAP Sierra Leone, Freetown, Sierra Leone.
Palak PatelU.S. Centers for Disease Control and Prevention, Atlanta GA, USA.
Mohamed FeikaICAP Sierra Leone, Freetown, Sierra Leone.
Samilia KamaraICAP Sierra Leone, Freetown, Sierra Leone.
Jerikatu BanguraICAP Sierra Leone, Freetown, Sierra Leone.
Unisa JallohICAP Sierra Leone, Freetown, Sierra Leone.
Musa KoromaICAP Sierra Leone, Freetown, Sierra Leone.
Zainab SankohICAP Sierra Leone, Freetown, Sierra Leone.
Henry SandyICAP Sierra Leone, Freetown, Sierra Leone.
Mame ToureICAP Sierra Leone, Freetown, Sierra Leone.
Thompson Uwhomena IgbuWorld Health Organization, Freetown, Sierra Leone.
Tom SesaySierra Leone Ministry of Health and Sanitation, Freetown, Sierra Leone.
Ruby N FayorseyICAP, NY, USA.
Neetu AbadU.S. Centers for Disease Control and Prevention, Atlanta GA, USA.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Background: Vaccination coverage for the second dose of the measles-containing vaccine (MCV2) among children has remained stagnant in Sierra Leone at nearly 67% since its introduction in 2015. Identifying community-specific barriers faced by caregivers in accessing MCV2 services for their children and by health workers in delivering MCV2 is key to informing strategies to improve vaccination coverage. Methods: We used Photovoice, a participatory method using photographs and narratives to understand community barriers to MCV2 uptake from March- September 2020. Six female and five male caregivers of MCV2-eligible children (15-24 months of age), and six health care workers (HCWs) in Freetown, Sierra Leone participated. After having an orientation to photovoice, they photographed barriers related to general immunization and MCV2 uptake in their community. This was followed by facilitated discussions where participants elaborated on the barriers captured in the photos. Transcripts from the six immunization-related discussions were analyzed to deduce themes through open-ended coding. A photo exhibition was held for participants to discuss the barriers and suggested solutions with decision-makers, such as the ministry of health. Results: We identified and categorized nine themes into three groups: 1) individual or caregiver level barriers (e.g., caregivers' lack of knowledge on MCV2, concerns about vaccine side effects, and gender-related barriers); 2) health system barriers, such as HCWs' focus on children below one year and usage of old child health cards; and 3) contextual barriers, such as poverty, poor infrastructure, and the COVID-19 pandemic. Participants suggested the decision-makers to enhance community engagement with caregivers and HCW capacity including, increasing accountability of their work using performance-based approaches, among different strategies to improve MCV2 uptake. Conclusion: Photovoice can provide nuanced understanding of community issues affecting MCV2. As a methodology, it should be integrated in broader intervention planning activities to facilitate the translation of community-suggested strategies into action.

Indexed as

Community participationImmunization barriersMCV2PhotovoiceSHOWeD

Identifiers

PMID37577263
PMCPMC10422676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.